TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Tesamorelin therapy has been shown to trigger lipolysis, or fat burning, especially around the abdominal area [9]
If you take 1,000mg of a nutrient but your body can only absorb 50mg, you are putting unnecessary stress on your digestive system while seeing minimal benefit
We emphasize consistent purity and traceability across all research batches
Local health experts say that while the move could make the sought-after drugs more accessible, it may also leave behind those who need them most
Crook H, Raza S, Nowell J, Young M, Edison P